Angle Health announced a $200 million Series C funding round, led by Vitruvian Partners. Additional participants included Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. This funding round values the health insurance startup at $2.7 billion.
Alongside the Series C funding, Angle Health also initiated a $400 million tender offer. This offer provides an opportunity for employees to cash out a portion of their shares, which is expected to close later this month.
Founded in 2019 and a Y Combinator alum, Angle Health specializes in providing "level funded health plans" for small businesses. These plans offer a middle ground between fully insured and self-funded options, aiming to provide predictable payments and potential savings for businesses. The company utilizes an AI-powered platform to help businesses select and manage plans, integrating with existing payroll and HR systems.
Angle Health currently serves over 5,000 businesses. The company has stated that it is profitable, indicating a stable financial position as it secures new investment.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
Angle Health, a health insurance startup, secured $200 million in Series C funding and a $400 million tender offer, valuing the company at $2.7 billion. This funding round and tender offer allow employees to cash out shares, impacting the company's financial structure and growth trajectory in the health insurance sector.